期刊文献+

医院内获得性感染洋葱伯克霍尔德菌的临床分布及耐药性分析 被引量:6

下载PDF
导出
摘要 目的:了解2006年1月至2008年9月我院临床分离的洋葱伯克霍尔德菌的标本来源、临床分布和耐药性。方法:用MicroScan AutoSCAN-4全自动微生物鉴定及药敏系统及配套试剂进行细菌鉴定及药敏试验,并分析结果。结果:2006-2008年9月共分离出122株洋葱伯克霍尔德菌,痰标本中分离菌株数占86.1%(105/122),血液中占6.6%(8/122),深静脉留置管和引流液共占5.7%。细菌耐药性试验结果显示,洋葱伯克霍尔德菌对头孢菌素类以及氨基糖苷类抗菌药物耐药率均>80%;耐药率<50%的有哌拉西林/他唑巴坦(28.2%)、亚胺培南(31.5%)和复方新诺明(40.8%)。结论:洋葱伯克霍尔德菌对多数抗生素具有较高的耐药性,临床抗感染治疗应以分离菌株的体外抗菌药物敏感性为依据。
出处 《实用医学杂志》 CAS 北大核心 2010年第2期314-315,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献5

二级参考文献13

  • 1杨华,田彬,徐海茹,岳娜,李金,胡志东.临床患者分离的洋葱伯克霍尔德菌耐药性分析[J].天津医科大学学报,2005,11(4):566-567. 被引量:1
  • 2Coenye T, Vandamme P, Govan J R, et al. Taxonomy and identification of the Burkholdefia cepacia complex [J]. J Clin Microbiol, 2001, 39(10) :3427-3436.
  • 3Loukil C, Saizou C, Doit C, et al. Epidemiologic investigation Of Burkholderia cepacia acquisition in two pediatric intensive care units [J]. Infect Control Hosp Epidemiol, 2003,24(9) :707-710.
  • 4Siddiqui A H, Mulligan M E, Mahenthiralingam E, et al. An episodic outbreak of genetically related Burkholderia cepacia among non-cystic fibrosis patients at a university hospital [J]. Infect Control Hosp Epidemiol, 2001, 22(7) :419-422.
  • 5[1]Li F K,Chan K W,Chan T M,et al.Burkholderia urinary tract infection after renal transplantation[J].Transpl Infect Dis,2003,5 (1):59-61.
  • 6[2]Hancock R E.Resistance mechanisms in Pesudomonas aeruginosa and other non-fernentative gram-negative bacteria[J].Clin Infect Dis,1998,27,(Suppl 1):S93-99.
  • 7Speert DP, Henry D, Vandanme P, et al. Epidemiology of burkholderiacepacia complex in patients with cysticfibrosis, Canada. Emerg Infect Dis, 2002,8(2)181-187.
  • 8Lu DC, Chang SC, Chen YC, et al. Burkholderia cepacia bacteremia: a retrospective analysis of 70 episodes. J Formos Med Assoc, 1997, 96( 12 ): 972-978.
  • 9Ramsey AH, Skonieczny P, Cooliddge DT, et al. Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist. Infect Control Hosp Epidemiol, 2001,22(7):423-426.
  • 10Huang CH, Jang TN, Liu CY, et al. Characteristics of patients with burkholderia cepacia bacteremia. J Microbiol Immunol Infect, 2001,34(3) :215-219.

共引文献51

同被引文献55

  • 1王洪斌,何代平,蒋红梅,胡美玲.高原地区医院感染的细菌学研究[J].西南军医,2005,7(2):1-2. 被引量:8
  • 2赵艳华,吕岳峰.洋葱伯克霍尔德菌研究进展[J].国际检验医学杂志,2006,27(7):651-652. 被引量:18
  • 3胡桃红,梁珺,赵贵峰.恶性肿瘤死亡患者医院感染分析[J].现代预防医学,2006,33(9):1691-1692. 被引量:4
  • 4Kamboj M, Sepkowitz K A. Nosocomial infections in patients with cancer[J]. Lancet Oneol, 2009, 10(6) :589-597.
  • 5Vento S, Cainelli F, Temesgen Z. Lung infections after cancer ehemotherapy[J]. Lancet Oncol, 2008, 9(10):982-992.
  • 6Alp E, Gtiven M, Yildiz O, et al. Incidence, risk factors and mortality of nosoeomial pneumonia in intensive care units: a pro spective study [J]. Ann Clin Mierobiol Antimicrob, 2004, 3(17):1 7.
  • 7Miano T A, Reichert M G, Houle T T, et al. Nosocomial pneu- monia risk and stress ulcer prophylaxis: a comparison of panto prazole vs ranitidine in cardiothoracic surgery patients [J]. Chest, 2009,136(2) :440-447.
  • 8Yamada Y, Sekine Y, Suzuki H, et al. Trends of bacterial colo nisation and the risk of postoperative pneumonia in lung cancer patients with chronic obstructive pulmonary disease[J]. Eur J Cardiothorac Surg, 2010, 37(4) :752-757.
  • 9Aliberti S, Amir A, Peyrani P, et ah Incidence, etiology, tim- ing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia[J]. Chest, 2008, 134 (5) : 955-962.
  • 10Kilgore M L, Ghosh K, Beavers C M, et al. The costs of noso- comial infections[J]. Med Care, 2008,46(1) : 101-104.

引证文献6

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部